GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating ...
Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...
Learn how new brain scans link long COVID to changes in the dopamine system that may help explain fatigue, brain fog, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results